CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - emergency - Management
Is oral ulipristal acetate emergency contraception safe during pregnancy?
- Oral ulipristal acetate emergency contraception should not be given to a woman with a known or suspected pregnancy.
- There are extremely limited data available on the effects to a fetus if exposure occurs, but there have been no reported problems with the very small number of pregnancies to date [ABPI Medicines Compendium, 2009].
- The European Medicines Agency has requested that a pregnancy register is set up to collate further data on exposure during pregnancy to ulipristal acetate (including either undetected pregnancy before provision of ulipristal acetate or treatment failure) [HRA Pharma, 2010].
© NHS Institute for Innovation and Improvement